(Philadelphia, PA) - Dr. Michael Ming has been appointed an Assistant Professor in the Department of Dermatology at the University of Pennsylvania School of Medicine.

After earning his medical degree in 1993 from Harvard Medical School, Dr. Ming completed an internship at Massachusetts General Hospital in Boston, MA, a residency at Harvard Medical School and fellowships at the University of California in San Francisco, CA, and the Veteran Affairs Medical Center in San Francisco.

From 1999 to 2000, Dr. Ming served as Clinical Instructor in Pathology at the University of California, and from 2000 to 2002 as Instructor of Dermatology at the University of Pennsylvania School of Medicine.

Dr. Ming's research interests are risk factors related to melanoma and dysplastic moles, and analyzing the microscopic misdiagnosis of melanoma. He is currently developing models for predicting the occurrence of second primary melanomas and working to identify the characteristics associated with microscopic misdiagnosis of melanoma. Dr. Ming is also assessing the attitudes and beliefs of dermatologists and dermapathologists on the relationship between dysplastic moles and melanoma. .

In 2000, Dr. Ming received the Award for Young Investigators in Dermatology from the American Academy of Dermatology.

Dr. Ming has co-authored original research studies and abstracts in peer-reviewed journals and written or co-written editorials, reviews and chapters for print publications.

Dr. Ming holds memberships in a number of national professional societies, including the American Academy of Dermatology, the American Medical Association, and the Massachusetts Medical Society.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.